In a field trial using IBR MLV vaccine at arrival, the incidence of upper respiratory disease was reduced from 17.2% in 3371 unvaccinated calves to 1 % in 3345 vaccinates (RR = 16; P<O.OOOO),us A well-designed trial using IBR MLV vaccine given on arrival failed to show benefits in health performance.